Patients with diffuse uveitis and inactive toxoplasmic retinitis lesions test PCR positive for Toxoplasma gondii in their vitreous and blood

British Journal of Ophthalmology

Volumn 98, Issue 7, 2014, Pages 937-940

  Novais, Eduardo Amorim ^a   Commodaro, Alessandra G ^a,b   Santos, Fábio ^a,c   Muccioli, Cristina ^a   Maia, André ^a   Nascimento, Heloisa ^a   Moeller, Cecilia T A ^a   Rizzo, Luiz V ^c   Grigg, Michael E ^b   Belfort, Rubens ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; CLINDAMYCIN; COTRIMOXAZOLE; GANCICLOVIR; IMMUNOGLOBULIN G ANTIBODY; PARASITE ANTIBODY; PREDNISONE; PROTOZOAL DNA; STEROID;

ANTIBODY DETECTION; ARTICLE; BLOOD CULTURE; CASE REPORT; CHORIORETINITIS; CONTROLLED STUDY; DNA SEQUENCE; DRUG DOSE REDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE EXAMINATION; EYE REDNESS; GENE LOCUS; GENOTYPE; GRANULOMA; HUMAN; HYPEREMIA; IRIDOCYCLITIS; LENS IMPLANT; LENS IMPLANTATION; NESTED POLYMERASE CHAIN REACTION; NONHUMAN; PARASITE LOAD; PHACOEMULSIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETINA DISEASE; RETINA GRANULOMA; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT DURATION; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS BODY; VITRITIS;

DIAGNOSTIC TESTS/INVESTIGATION; IMMUNOLOGY; INFECTION; INFLAMMATION; TREATMENT SURGERY;

ANTI-INFECTIVE AGENTS; ANTIBODIES, PROTOZOAN; ANTIPROTOZOAL AGENTS; CHRONIC DISEASE; DNA, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPING TECHNIQUES; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PREDNISONE; REAL-TIME POLYMERASE CHAIN REACTION; RETINITIS; SEROTYPING; TOXOPLASMA; TOXOPLASMOSIS, OCULAR; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; UVEITIS; VITRECTOMY; VITREOUS BODY;

EID: 84902363278     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-304184     Document Type: Article

References (22)

1. Robert-Gangneux F, Darde ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012;25:264-96.
2. Dubey JP, Lago EG, Gennari SM, et al. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology 2012:139:1375-424.
3. Montoya JG, Remington JS. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis 1996;23:277-82. (Pubitemid 26264909)
4. Nussenblatt RB, Belfort R Jr. Ocular toxoplasmosis. An old disease revisited. JAMA 1994;271:304-7. (Pubitemid 24030759)
5. Belfort R Jr, Silveira C, Muccioli C. Chapter 85 - ocular toxoplasmosis. Retina. 5th edn. London: W.B. Saunders, 2013:1494-9.
6. Arévalo JF, Belfort R Jr, Espinoza JV, et al. Retinal and choroidal manifestations of toxoplasmosis. In: Arévalo JF. ed. Retinal and choroidal manifestations of selected systemic diseases: Springer New York, 2013:79-104.
7. Harper TW, Miller D, Schiffman JC, et al. Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis. Am J Ophthalmol 2009;147:140-47 e2.
8. Van Gelder RN. Applications of the polymerase chain reaction to diagnosis of ophthalmic disease. Surv Ophthalmol 2001;46:248-58. (Pubitemid 34003580)
9. Kong JT, Grigg ME, Uyetake L, et al. Serotyping of Toxoplasma gondii infections in humans using synthetic peptides. J Infect Dis 2003;187:1484-95. (Pubitemid 36549695)
10. Fekkar A, Bodaghi B, Touafek F, et al. Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol 2008;46:1965-7. (Pubitemid 351831828)
11. Bottos J, Miller RH, Belfort RN, et al. Bilateral retinochoroiditis caused by an atypical strain of Toxoplasma gondii. Br J Ophthalmol 2009;93:1546-50.
12. Commodaro AG, Belfort RN, Rizzo LV, et al. Ocular toxoplasmosis: an update and review of the literature. Mem Inst Oswaldo Cruz 2009;104:345-50.
13. Silveira C, Vallochi AL, Rodrigues da Silva U, et al. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol 2011;95:396-400.
14. McLeod R, Boyer KM, Lee D, et al. Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009). Clin Infect Dis 2012;54:1595-605.
15. Vaudaux JD, Muccioli C, James ER, et al. Identification of an atypical strain of toxoplasma gondii as the cause of a waterborne outbreak of toxoplasmosis in Santa Isabel do Ivai, Brazil. J Infect Dis 2010;202:1226-33.
16. Shahsuvaryan ML. Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusion. Int J Ophthalmol 2012;5:759-70.
17. Jonas JB. Intravitreal triamcinolone acetonide: a change in a paradigm. Ophthalmic Res 2006;38:218-45. (Pubitemid 44213982)
18. Asencio-Duran M, Vallejo-Garcia JL, Pastora-Salvador N, et al. Vitreous diagnosis in neoplastic diseases. Mediators Inflamm 2012;2012:930704.
19. Fang R, Feng H, Hu M, et al. Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii. Vet Parasitol 2012;187:140-6.
20. Hoseinian Khosroshahi K, Ghaffarifar F, D'Souza S, et al. Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis. Vaccine 2011;29:778-83.
21. Bai Y, He S, Zhao G, et al. Toxoplasma gondii: bioinformatics analysis, cloning and expression of a novel protein TgIMP1. Exp Parasitol 2012;132:458-64.
22. Lee H, Lytton-Jean AK, Chen Y, et al. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat Nanotechnol 2012;7:389-93.